1-3 of 3
Cornelia Bratengeier
Close
Sort by
Journal Articles

High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia

Ersi Voskaridou, Dimitrios Christoulas, Athanasios Papatheodorou, Cornelia Bratengeier, Eleni Plata, Despoina Kaliontzi, Wolfgang Woloszczuk, Evangelos Terpos
Journal: Blood
Blood (2010) 116 (21): 1010.
https://doi.org/10.1182/blood.V116.21.1010.1010
Published: 2010
Journal Articles

Circulating Levels of the Wnt Inhibitors Dickkopf-1 and Sclerostin In Different Phases of Multiple Myeloma: Alterations Post-Therapy with Lenalidomide and Dexamethasone with or without Bortezomib

Evangelos Terpos, Dimitrios Christoulas, Maria Gkotzamanidou, Cornelia Bratengeier, Maria Gavriatopoulou, Magdalini Migkou, Athanasios Papatheodorou, Efstathios Kastritis, Wolfgang Woloszczuk, Meletios A. Dimopoulos
Journal: Blood
Blood (2010) 116 (21): 2963.
https://doi.org/10.1182/blood.V116.21.2963.2963
Published: 2010
Journal Articles

High Serum Sclerostin Correlates with Advanced Stage, Increased Bone Resorption, Reduced Osteoblast Function, and Poor Survival in Newly-Diagnosed Patients with Multiple Myeloma.

Evangelos Terpos, Dimitrios Christoulas, Eirini Katodritou, Cornelia Bratengeier, Brigitte Lindner, Silvia Harmelin, Gerhard Hawa, Georgios Boutsikas, Magdalini Migkou, Maria Gavriatopoulou, Eurydiki Michalis, Anastasia Pouli, Efstathios Kastritis, Konstantinos Zervas, Meletios A. Dimopoulos
Journal: Blood
Blood (2009) 114 (22): 425.
https://doi.org/10.1182/blood.V114.22.425.425
Published: 2009